Cargando…

Peri-Transplant Change in AFP Level: a Useful Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation

Pretransplant alpha-fetoprotein (AFP) is a useful tumor marker predicting recurrence of hepatocellular carcinoma (HCC). Little is known, however, about the relationship between changes in AFP concentration and prognosis. This study investigated the clinical significance of change in peri-transplant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoo, Tae, Lee, Kwang-Woong, Yi, Nam-Joon, Choi, Young Rok, Kim, Hyeyoung, Suh, Suk-Won, Jeong, Jae Hong, Lee, Jeong-Moo, Suh, Kyung-Suk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2016
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900995/ https://www.ncbi.nlm.nih.gov/pubmed/27366001 http://dx.doi.org/10.3346/jkms.2016.31.7.1049

Ejemplares similares

Response-Guided Therapy for Hepatitis C Virus Recurrence Based on Early Protocol Biopsy after Liver Transplantation
por: Kim, Hyeyoung, et al.
Publicado: (2015)

Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation
por: Lee, Ju-Yeun, et al.
Publicado: (2014)

Outcomes of Living Donor Liver Transplantation in Patients With a History of Ruptured Hepatocellular Carcinoma
por: Lee, Hwi Yeol, et al.
Publicado: (2021)

Fatigue and related factors after liver transplantation
por: Hong, Kwangpyo, et al.
Publicado: (2015)

Recurrence in patients with totally necrotic nodules of hepatocellular carcinoma after liver transplantation: “totally” an inaccurate description
por: Kim, Jiyoung, et al.
Publicado: (2023)

Risk Factors for the Adverse Events after Conversion from Twice-Daily to Once-Daily Tacrolimus in Stable Liver Transplantation Patients
por: Suh, Suk-Won, et al.
Publicado: (2016)

Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation
por: Kim, Hyeyoung, et al.
Publicado: (2014)

Long Term Outcomes of Pediatric Liver Transplantation According to Age
por: Byun, Jeik, et al.
Publicado: (2014)

Bile duct invasion can be an independent prognostic factor in early stage hepatocellular carcinoma
por: Jang, Ye-Rang, et al.
Publicado: (2015)

Optimal Tailored Screening Protocol after Living Donor Liver Transplantation for Hepatocellular Carcinoma
por: Park, Min-Su, et al.
Publicado: (2014)

Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence
por: Kang, Seong Hee, et al.
Publicado: (2018)

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome in liver transplantation
por: Cho, Ara, et al.
Publicado: (2021)

Risk Factors Affecting Outcomes in Pediatric Liver Transplantation: A Real-World Single-Center Experience
por: Hong, Suk Kyun, et al.
Publicado: (2021)

Tailored Prediction Model of Survival after Liver Transplantation for Hepatocellular Carcinoma
por: Jamtani, Indah, et al.
Publicado: (2021)

LigaSure versus monopolar cautery for recipient hepatectomy in liver transplantation: a propensity score-matched analysis
por: Lee, Jeong-Moo, et al.
Publicado: (2021)

Preoperative Selective Desensitization of Live Donor Liver Transplant Recipients Considering the Degree of T Lymphocyte Cross-Match Titer, Model for End-Stage Liver Disease Score, and Graft Liver Volume
por: Hong, Geun, et al.
Publicado: (2014)

Long-Term Outcomes of Abdominal Wall Reconstruction with Expanded Polytetrafluoroethylene Mesh in Pediatric Liver Transplantation
por: Kim, Jiyoung, et al.
Publicado: (2021)

Wearable recording video technology for surgical training in living donor liver transplantation
por: Lee, Shin Ae, et al.
Publicado: (2020)

Clinical usefulness of T1-weighted MR cholangiography with Gd-EOB-DTPA for the evaluation of biliary complication after liver transplantation
por: Lim, Chang Jin, et al.
Publicado: (2021)

Impact of Model for End-Stage Liver Disease allocation system on outcomes of deceased donor liver transplantation: A single-center experience
por: Park, Han Sang, et al.
Publicado: (2021)

Modified Charlson comorbidity index as a survival prediction tool for older patients after liver transplantation
por: Choi, Jiho, et al.
Publicado: (2023)

The Model for End-Stage Liver Disease Score-Based System Predicts Short Term Mortality Better Than the Current Child-Turcotte-Pugh Score-Based Allocation System during Waiting for Deceased Liver Transplantation
por: Hong, Geun, et al.
Publicado: (2013)

Acute appendicitis after liver transplantation: A single center experience and review of the literature
por: Jamtani, Indah, et al.
Publicado: (2020)

Hepatitis B immunoglobulin prophylaxis for de novo hepatitis B infection in liver transplantation: a 30-year experience
por: Jung, Hye-Sol, et al.
Publicado: (2022)

Optimal Intervention for Initial Treatment of Anastomotic Biliary Complications After Right Lobe Living Donor Liver Transplantation
por: Kim, Min Seob, et al.
Publicado: (2022)

Living Donor Liver Transplantation for an Infant with Osteogenesis Imperfecta and Intrahepatic Cholestasis: Report of a Case
por: Choi, YoungRok, et al.
Publicado: (2014)

Factors associated with rituximab-mediated B cell depletion in ABO-incompatible adult living donor liver transplantation
por: Hong, Suk Kyun, et al.
Publicado: (2023)

Heterogeneous living donor hepatic fat distribution on MRI chemical shift imaging
por: Choi, YoungRok, et al.
Publicado: (2015)

Validation for models for tumor recurrence after liver transplantation in hepatectomy patients
por: Kim, Sung Joon, et al.
Publicado: (2022)

Efficacy of Liver Resection for Single Large Hepatocellular Carcinoma in Child-Pugh A Cirrhosis: Analysis of a Nationwide Cancer Registry Database
por: Hong, Suk Kyun, et al.
Publicado: (2021)

Emergency department visits and unanticipated readmissions after liver transplantation: A retrospective observational study
por: Oh, Seung-Young, et al.
Publicado: (2018)

Korean Patients Undergoing Deceased Donor Liver Transplantation for Alcoholic Liver Disease Have Non-Inferior Survival Outcomes than for Hepatitis B Virus: a Real-World Experience without Minimum Abstinence before Transplantation
por: Hong, Suk Kyun, et al.
Publicado: (2017)

Sirolimus Prolongs Survival after Living Donor Liver Transplantation for Hepatocellular Carcinoma Beyond Milan Criteria: A Prospective, Randomised, Open-Label, Multicentre Phase 2 Trial
por: Lee, Kwang-Woong, et al.
Publicado: (2020)

No diffuse intrahepatic biliary stricture after ABO-incompatible adult living donor liver transplantation using tailored rituximab-based desensitization protocol
por: Natsuda, Koji, et al.
Publicado: (2021)

Living donor liver transplantation should be cautiously considered as initial treatment in recurrent hepatocellular carcinoma within the Milan criteria after curative liver resection
por: Kim, Jong Man, et al.
Publicado: (2020)

Histopathologic factors affecting tumor recurrence after hepatic resection in colorectal liver metastases
por: Park, Min-Su, et al.
Publicado: (2014)

Alteration of MRP2 expression and the graft outcome after liver transplantation
por: Yi, Nam-Joon, et al.
Publicado: (2018)

Liver transplantation for advanced hepatocellular carcinoma
por: Lee, Hae Won, et al.
Publicado: (2016)

Soluble suppression of tumorigenicity 2 is a potential predictor of post-liver transplant renal outcomes
por: Moon, Jong Joo, et al.
Publicado: (2023)

Portal vein reconstruction in pediatric liver transplantation using end-to-side jump graft: A case report
por: Lee, Jaewon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qru5f5h94tl0a87andp6a2htrs